These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men. Cornelisse VJ; Riley B; Medland NA Med J Aust; 2024 Apr; 220(7):381-386. PubMed ID: 38479437 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention. Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546 [TBL] [Abstract][Full Text] [Related]
4. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and Perils. Siguier M; Molina JM ACS Infect Dis; 2018 May; 4(5):660-663. PubMed ID: 29570279 [TBL] [Abstract][Full Text] [Related]
5. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial. Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444 [TBL] [Abstract][Full Text] [Related]
6. Correspondence on "A case for the inclusion of doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men in sub-Saharan African countries' guidelines for the management of sexually transmitted infections" by "Dzinamarira Dzinamarira T; Moyo E; Murewanhema G Sex Transm Infect; 2024 Jan; 100(1):57. PubMed ID: 37833057 [No Abstract] [Full Text] [Related]
7. Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy-PEP, Doxy-PrEP). Werner RN; Schmidt AJ; Potthoff A; Spornraft-Ragaller P; Brockmeyer NH; J Dtsch Dermatol Ges; 2024 Mar; 22(3):466-478. PubMed ID: 38123738 [TBL] [Abstract][Full Text] [Related]
8. Already current practice? A snapshot survey on doxycycline use for prevention of sexually transmitted infections in parts of the German MSM community. Hornuss D; Mathé P; Usadel S; Zimmermann S; Müller M; Rieg S Infection; 2023 Dec; 51(6):1831-1834. PubMed ID: 37608042 [TBL] [Abstract][Full Text] [Related]
9. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Cornelisse VJ; Ong JJ; Ryder N; Ooi C; Wong A; Kenchington P; Giola M; Donovan B; Dean JA; Molina JM; Medland NA Sex Health; 2023 Apr; 20(2):99-104. PubMed ID: 36927481 [TBL] [Abstract][Full Text] [Related]
10. The relationship between HIV pre-exposure prophylaxis, sexually transmitted infections, and antimicrobial resistance: a qualitative interview study of men who have sex with men. Williams ADN; Wood F; Gillespie D; Couzens Z; Hughes K; Hood K BMC Public Health; 2022 Nov; 22(1):2222. PubMed ID: 36447181 [TBL] [Abstract][Full Text] [Related]
11. Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia. Arapali T; Grulich AE; Heywood AE; Chan C; Fraser D; Zablotska IB; Holt M; Vaccher SJ; Bavinton BR Sex Transm Dis; 2023 Mar; 50(3):144-149. PubMed ID: 36730780 [TBL] [Abstract][Full Text] [Related]
12. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data. Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA; Lancet Infect Dis; 2022 Aug; 22(8):1231-1241. PubMed ID: 35643090 [TBL] [Abstract][Full Text] [Related]
13. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ; JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528 [TBL] [Abstract][Full Text] [Related]
14. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Molina JM; Charreau I; Chidiac C; Pialoux G; Cua E; Delaugerre C; Capitant C; Rojas-Castro D; Fonsart J; Bercot B; Bébéar C; Cotte L; Robineau O; Raffi F; Charbonneau P; Aslan A; Chas J; Niedbalski L; Spire B; Sagaon-Teyssier L; Carette D; Mestre SL; Doré V; Meyer L; Lancet Infect Dis; 2018 Mar; 18(3):308-317. PubMed ID: 29229440 [TBL] [Abstract][Full Text] [Related]
15. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Bolan RK; Beymer MR; Weiss RE; Flynn RP; Leibowitz AA; Klausner JD Sex Transm Dis; 2015 Feb; 42(2):98-103. PubMed ID: 25585069 [TBL] [Abstract][Full Text] [Related]
16. "The Main Concern is HIV, Everything Else is Fixable": Indifference Toward Sexually Transmitted Infections in the Era of Biomedical HIV Prevention. Sarno EL; Macapagal K; Newcomb ME AIDS Behav; 2021 Aug; 25(8):2657-2660. PubMed ID: 33745099 [TBL] [Abstract][Full Text] [Related]
17. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men. Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J; Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145 [TBL] [Abstract][Full Text] [Related]
18. Latent Class Analysis of Sexual Behaviours and Attitudes to Sexually Transmitted Infections Among Gay and Bisexual Men Using PrEP. Traeger MW; Murphy D; Ryan KE; Asselin J; Cornelisse VJ; Wilkinson AL; Hellard ME; Wright EJ; Stoové MA AIDS Behav; 2022 Jun; 26(6):1808-1820. PubMed ID: 34782934 [TBL] [Abstract][Full Text] [Related]
19. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021. Marcus U; Schink SB; Weber C BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369 [TBL] [Abstract][Full Text] [Related]
20. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women. Stewart J; Oware K; Donnell D; Violette LR; Odoyo J; Soge OO; Scoville CW; Omollo V; Mogaka FO; Sesay FA; McClelland RS; Spinelli M; Gandhi M; Bukusi EA; Baeten JM; N Engl J Med; 2023 Dec; 389(25):2331-2340. PubMed ID: 38118022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]